Ajjan, N., Soulebot, J. P., Triau, R.& Biron, G. (1980). Intradermal immunization with rabies vaccine. Journal of the American Medical Association 244, 2528–2531.
Anderson, L. J., Sikes, R. K., Langkop, L. W., Mann, J. M., Smith, J. S., Winkler, W. G. & Deitch, M. W. (1980). Post-exposure trial of a human diploid cell strain rabies vaccine. Journal of Infectious Diseases 142, 133–138.
Aoki, F. Y., Tyrrell, D. A. J., Hill, L. E. & Turner, G. S. (1975). Immunogenicity and acceptability of a human diploid cell culture rabies vaccine in volunteers. Lancet i, 660–662.
Atanasiu, P. (1973). Quantitative assay and potency test of antirabies serum and immunoglobulin. In Laboratory Techniques in Rabies, 3rd ed. (ed. Kaplan, M. M. and Koprowski, H.). World Health Organization Monograph series, no. 23, pp. 314–318. Geneva: World Health Organization.
Bahmanyar, M., Fayaz, A., Nour-Salehi, S., Mohammadi, M. & Koprowski, H. (1976). Successful protection of humans exposed to rabies infection. Post-exposure treatment with the new human diploid cell rabies vaccine and rabies serum. Journal of the American Medical Association 236, 2751–2754.
Boe, E. & Nyland, H. (1980). Guillain-Barre syndrome after vaccination with human diploid cell rabies vaccine. Scandinavian Journal of Infectious Diseases 12, 231–232.
Cox, J. H. & Schneider, L. G. (1976). Prophylactic immunization of humans against rabies by intradermal inoculations of human diploid cell culture vaccine. Journal of Clinical Microbiology 3, 96–101.
Furlong, J. & Lea, G. (1980). Rabies prophylaxis simplified. Lancet i, 1311.
Kleitman, W., Schottle, A., Klietmann, B. & Cox, I. (1981). In Cell culture rabies vaccines and their protective effect in man (ed. Kuwert, E. K., Wiktor, T. J. & Koprowski, H.), pp. 330–337. Geneva: International Green Cross.
Kuwert, E. K., Marcus, I. & Hoher, P. G. (1976). Neutralizing and complement-fixing antibody responses in pre- and post-exposure vaccinees to a rabies vaccine produced in human diploid cells. Journal of Biological Standardization 4, 244–262.
Lorenz, R. J. & Bögel, K. (1973). Methods of calculation: the Spearman-Kärber method. In Laboratory Techniques in Rabies, 3rd ed. (ed. Kaplan, M. M. & Koprowski, H.), World Health Organization Monograph series no. 23, pp. 321–329. Geneva: World Health Organization.
Miller, A. & Nathanson, N. (1977). Rabies: Recent advances in pathogenesis and control. Neurology 6, 511–519.
Morbidity and Mortality Weekly Report (1977). Rabies in a laboratory worker, New York. 26, 183–184.
Morbidity and Mortality Weekly Report (1981 a . Use of human diploid cell vaccine for post-exposure rabies treatment, Canada. 30 (22), 266–267.
Morbidity and Mortality Weekly Report (1981 b). Supplementary statement on Rabies Vaccine and Serologic testing 30 (42). 535–536.
Nicholson, K. G. & Prestage, H. (1982). Enzyme linked immunosorbent assay: a rapid reproducible test for the measurement of rabies antibody. Journal of Medical Virology 9, 43–49.
Nicholson, K. G., Turner, G. S. & Aoki, F. Y. (1978). Immunization with a human diploid cell strain of rabies virus vaccine. Two year results. Journal of Infections Diseases 137, 783–788.
Nicholson, K. G. & Turner, G. S. (1978). Studies with human diploid cell strain rabies vaccine and human antirahies immunoglobulin in man. Developments in Biological Standardization 40, 115–120.
Nicholson, K. G., Cole, P. J., Turner, G. S. & Harrison, P. (1979). Immune responses of humans to a human diploid cell strain of rabies virus vaccine: Lymphocyte transformation. production of virus neutralizing antibody, and induction of interferon. Journal of Infectious Diseases 140. 176–182.
Plotkin, S. A. & Wiktor, T. (1978). Rabies vaccination. Annual Reviews of Medicine 29, 583–591.
Rosanoff, E. & Tint, H. (1979). Responses to human diploid cell rabies vaccine: neutralizing antibody responses of vaccinees receiving booster doses of human diploid cell rabies vaccine. American Journal of Epidemiology 110, 322–327.
Seligman, E. B. (1973). The NIH test for potency. In Laboratory Techniques in Rabies, 3rd ed. (ed Kaplan, M. M. & Koprowski, H.). World Health Organization Monograph series no. 23, pp. 279–286. Geneva: World Health Organization.
Simona, R., Keller, H., Spengler, G., Gerber, H., Weiss, M. & Steck, F. (1979). Revakzination gegen Lyssa beim Menschen: Wirksamkeit verechiedener Boosterschemata. Schweizerische Medizinische Wochenschrift 109, 1702–1708.
Turner, G. S. (1977). An assessment of the current position of rabies vaccination in man. In Recent Advances in Clinical Virology (ed. Waterson, A. P.). pp. 79–92. London. Churchill Livingstone.
Turner, G. S., Aoki, F. Y., Nicholson, K. G.Tyrrell, D. A. J. & Hill, L. E. (1976). Human diploid cell strain rabies vaccine. Rapid prophylactic immunization of volunteers with small doses. Lancet i, 1379–1381.
Wiktor, T. J. & Koprowski, H. (1965). Successful immunisation of primates with rabies vaccine prepared in human diploid cells. Proceedings of the Society for experimental Biology & Medicine 118, 1069–1073.
World Health Organization Expert Committee on Rabies. Third Report (1957). World Health Organization Technical Report Series, no. 121.
World Health Organization Expert Committee on Rabies. Sixth Report (1973). World Health Organization Technical Report Series no. 523.
WHO/IABS (1978). Joint Symposium on the Standardization of rabies vaccines for human use produced in Tissue Culture (Rabies III) (ed. Hennessen, W. & Regamey, R. H.. Developments in Biological Standardization 40. pp. 29–34. 79–139. 159–168. Basel: S. Karger.